The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Open accessAbstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Due to its high prevalence, MS is the leading cause of non-traumatic neurological disability in young adults in the United States and Europe. The clinical disease course is variable and starts with reversible episodes of neurological disability in the third or fourth decade of life. This transforms into a disease of continuous and irreversible neurological decline by the sixth or seventh decade. Available therapies for MS patients have little benefit for patients who enter this irreversible phase of the disease. It is well established that irreversible loss of axons and neurons are the major cause of the irreversible and progressive neurological decline that most MS patients endure. This review discusses the etiology, mechanisms and progress made in determining the cause of axonal and neuronal loss in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationAutoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592 · cited 2×
“It is also possible that neurogenesis can occur in the adult mammalian brain including the production of interneurons in the human hippocampus (Altman and Das, 1965; Alvarez-Buylla and Garcia-Verdugo, 2002; Eriksson et al., 1998; Kaplan and Hinds, 1977; Kornack and Rakic, 2001; Kuhn et al., 1996;…”
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Kuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Cognitive dysfunction in multiple sclerosis.: I. Frequency, patterns, and prediction
Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.685 · Cited by 2,110
Luskin, M. B. (1993) · Neuron · doi:10.1016/0896-6273(93)90281-u · Cited by 1,803
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 18×
“…of sodium channels on demyelinated axons (Smith, 2007; Trapp and Stys, 2009; Waxman, 2006), and expression of neurotrophic factors by immune and CNS resident cells (Dutta et al., 2007; Martino, 2004; Nave, 2010; Nave and Trapp, 2008; Stadelmann et al., 2002, 2008; Trapp and Nave, 2008).”
InfluentialSelf-citationExtrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Neurogenesis in the Adult Rat: Electron Microscopic Analysis of Light Radioautographs
Kaplan, M. S., & Hinds, J. W. (1977) · Science · doi:10.1126/science.887941 · Cited by 1,475
Neurogenesis in Adult Subventricular Zone
Alvarez-Buylla, A., & Garcı́a-Verdugo, J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00629.2002 · Cited by 1,466
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 5×
“There is no reliable mechanism to identify cortical demyelination by routine brain imaging because cortical demyelination occurs without significant infiltration of hematogenous leukocytes (Bo et al., 2003a; Kidd et al., 1999; Peterson et al., 2001) and significant break down of the BBB.”
InfluentialSelf-citationThe natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Kleinschmidt-DeMasters, B. K., & Tyler, K. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051782 · Cited by 1,072
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Hawker, K., O'Connor, P., Freedman, M. S., Calabresi, P. A., Antel, J., Simon, J., Hauser, S., Waubant, E., Vollmer, T., Panitch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21867 · Cited by 934
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 3×
“The pore-forming subunit of N-type calcium channels (Kornek et al., 2001) and metabotropic glutamate receptors (Geurts et al., 2003) also accumulate in acutely demyelinated axons (Bitsch et al., 2000), and if inserted into the axolemma they may also contribute to axonal dysfunction and transection.”
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Self-citationThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia
Káradóttir, R., Cavelier, P., Bergersen, L. H., & Attwell, D. (2005) · Nature · doi:10.1038/nature04302 · Cited by 772
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766 · cited 2×
“Cortical demyelination is a prominent feature of postmortem MS brains (Bo et al., 2003a,b; Brownell and Hughes, 1962; Kidd et al., 1999; Kutzelnigg and Lassmann, 2005; Peterson et al., 2001).”
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 5×
“Estimates of cortical lesion load have been limited to immunocytochemical analysis of postmortem brains and may equal or exceed white matter lesion load (Bo et al., 2003a; Kutzelnigg and Lassmann, 2005).”
InfluentialSelf-citationGlutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Functional Hemichannels in Astrocytes: A Novel Mechanism of Glutamate Release
Ye, Z.-C., Wyeth, M. S., Baltan-Tekkok, S., & Ransom, B. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03588.2003 · Cited by 704
CNS energy metabolism as related to function
Ames, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00038-2 · Cited by 663
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659
Axon-Glial Signaling and the Glial Support of Axon Function
Nave, K.-A., & Trapp, B. D. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094309 · Cited by 658
Self-citationMyelination and the trophic support of long axons
Nave, K.-A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2797 · Cited by 648
Clifford, D. B., DeLuca, A., Simpson, D. M., Arendt, G., Giovannoni, G., & Nath, A. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70028-4 · Cited by 636
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · cited 15×
“When released in excess, glutamate activates ionotropic and metabotropic receptors, resulting in toxic cytoplasmic Ca2+ accumulation and cell death.”
InfluentialSelf-citationMultiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Self-citationNMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
The distribution of plaques in the cerebrum in multiple sclerosis
Brownell, B., & Hughes, J. T. (1962) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.25.4.315 · Cited by 543
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia
Micu, I., Jiang, Q., Coderre, E., Ridsdale, A., Zhang, L., Woulfe, J., Yin, X., Trapp, B. D., McRory, J. E., Rehak, R., et al. (2006) · Nature · doi:10.1038/nature04474 · Cited by 505
Self-citationMyelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons
Yin, X., Crawford, T. O., Griffin, J. W., Tu, P.-H., Lee, V. M.-Y., Li, C., Roder, J., & Trapp, B. D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01953.1998 · Cited by 496
Self-citationThalamic neurodegeneration in multiple sclerosis
Cifelli, A., Arridge, M., Jezzard, P., Esiri, M. M., Palace, J., & Matthews, P. M. (2002) · Annals of Neurology · doi:10.1002/ana.10326 · Cited by 490
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
De Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 489
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Self-citationAxonal pathology in multiple sclerosis: relationship to neurologic disability
Trapp, B. D., Ransohoff, R., & Rudick, R. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199906000-00008 · Cited by 475
Self-citationAssembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Srinivasan, R., Sailasuta, N., Hurd, R., Nelson, S., & Pelletier, D. (2005) · Brain · doi:10.1093/brain/awh467 · Cited by 465
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis
Wegner, C., Esiri, M. M., Chance, S. A., Palace, J., & Matthews, P. M. (2006) · Neurology · doi:10.1212/01.wnl.0000237551.26858.39 · Cited by 441
Cognitive Dysfunction in Multiple Sclerosis
Guimarães, J., & Sá, M. J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00074 · Cited by 427
Stadelmann, C., Kerschensteiner, M., Misgeld, T., Brück, W., Hohlfeld, R., & Lassmann, H. (2002) · Brain · doi:10.1093/brain/awf015 · Cited by 425
The generation, migration, and differentiation of olfactory neurons in the adult primate brain
Kornack, D. R., & Rakic, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074998 · Cited by 424
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Dutta, R., & Trapp, B. D. (2007) · Neurology · doi:10.1212/01.wnl.0000275229.13012.32 · Cited by 412
Self-citationMitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406 · cited 2×
“Excessive axoplasmic Ca2+ accumulation will cause a vicious cycle of impaired mitochondrial operation, reduced energy production and compromised axonal transport (Mahad et al., 2008a; Smith, 2007; Trapp and Stys, 2009; Waxman, 2006).”
Natural history of multiple sclerosis
Weinshenker, B. G. (1994) · Annals of Neurology · doi:10.1002/ana.410360704 · Cited by 405
Axonal conduction and injury in multiple sclerosis: the role of sodium channels
Waxman, S. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2023 · Cited by 397
Regional hippocampal atrophy in multiple sclerosis
Sicotte, N. L., Kern, K. C., Giesser, B. S., Arshanapalli, A., Schultz, A., Montag, M., Wang, H., & Bookheimer, S. Y. (2008) · Brain · doi:10.1093/brain/awn030 · Cited by 389
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis
Filippi, M. (2003) · Brain · doi:10.1093/brain/awg038 · Cited by 371
Pencea, V., Bingaman, K. D., Freedman, L. J., & Luskin, M. B. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7768 · Cited by 368
Hohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Axonal changes in chronic demyelinated cervical spinal cord plaques
Lovas, G., Szilagyi, N., Majtenyi, K., Palkovits, M., & Komoly, S. (2000) · Brain · doi:10.1093/brain/123.2.308 · Cited by 356
MRI in multiple sclerosis: current status and future prospects
Bakshi, R., Thompson, A. J., Rocca, M. A., Pelletier, D., Dousset, V., Barkhof, F., Inglese, M., Guttmann, C. R., Horsfield, M. A., & Filippi, M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70137-6 · Cited by 348 · cited 11×
“Axonal swelling correlated with T1 and MTR changes on MRI (but not T2 only MRI changes) (Fisher et al., 2007).”
InfluentialSkulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., & Goebels, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308689100 · Cited by 348
The link between excitotoxic oligodendroglial death and demyelinating diseases
Matute, C., Alberdi, E., Domercq, M., Pérez-Cerdá, F., Pérez-Samartı́n, A., & Sánchez-Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 348
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Weiner, H. L. (2009) · Annals of Neurology · doi:10.1002/ana.21640 · Cited by 344
Evangelou, N. (2001) · Brain · doi:10.1093/brain/124.9.1813 · Cited by 323
General mechanisms of axonal damage and its prevention
Stys, P. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.031 · Cited by 314
Reddy, H., Narayanan, S., Arnoutelis, R., Jenkinson, M., Antel, J., Matthews, P. M., & Arnold, D. L. (2000) · Brain · doi:10.1093/brain/123.11.2314 · Cited by 312
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Li, S., & Stys, P. K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01190.2000 · Cited by 307
Brück, W. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5002-7 · Cited by 300
Grey Matter Pathology in Multiple Sclerosis
Vercellino, M., Plano, F., Votta, B., Mutani, R., Giordana, M. T., & Cavalla, P. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000190067.20935.42 · Cited by 295
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Cox, A. L., Thompson, S. A. J., Jones, J. L., Robertson, V. H., Hale, G., Waldmann, H., Compston, D. A. S., & Coles, A. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200535075 · Cited by 291
Wujek, J. R., Bjartmar, C., Richer, E., Ransohoff, R. M., Yu, M., Tuohy, V. K., & Trapp, B. D. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.1.23 · Cited by 289
Self-citationExtensive Hippocampal Demyelination in Multiple Sclerosis
Geurts, J. J. G., Bö, L., Roosendaal, S. D., Hazes, T., Daniëls, R., Barkhof, F., Witter, M. P., Huitinga, I., & van der Valk, P. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181461f54 · Cited by 287
Axonal loss in normal-appearing white matter in a patient with acute MS
Bjartmar, C., Kinkel, R. P., Kidd, G., Rudick, R. A., & Trapp, B. D. (2001) · Neurology · doi:10.1212/wnl.57.7.1248 · Cited by 281
Self-citationProgress in determining the causes and treatment of multiple sclerosis
Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 278
Kapoor, R., Furby, J., Hayton, T., Smith, K. J., Altmann, D. R., Brenner, R., Chataway, J., Hughes, R. A., & Miller, D. H. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70131-9 · Cited by 268
Transection of Major Histocompatibility Complex Class I-Induced Neurites by Cytotoxic T Lymphocytes
Medana, I., Martinic, M. A., Wekerle, H., & Neumann, H. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61755-5 · Cited by 266
Narayanan, S., Fu, L., Pioro, E., De Stefano, N., Collins, D. L., Francis, G. S., Antel, J. P., Matthews, P. M., & Arnold, D. L. (1997) · Annals of Neurology · doi:10.1002/ana.410410314 · Cited by 264
Tekkök, S. B., & Goldberg, M. P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04237.2001 · Cited by 255
Rocca, M. A., Colombo, B., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., Comi, G., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70171-x · Cited by 254
White Matter Injury Mechanisms
Stys, P. (2004) · Current Molecular Medicine · doi:10.2174/1566524043479220 · Cited by 252
Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., Stastny, P., Douek, D. C., Koup, R. A., Racke, M. K., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4025 · Cited by 250
Sánchez, I., Hassinger, L., Paskevich, P. A., Shine, H. D., & Nixon, R. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05095.1996 · Cited by 250
Functional Analysis of the Mouse Scn8a Sodium Channel
Smith, M. R., Smith, R. D., Plummer, N. W., Meisler, M. H., & Goldin, A. L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06093.1998 · Cited by 248
TH1-TH2: a Procrustean paradigm
Gor, D. O., Rose, N. R., & Greenspan, N. S. (2003) · Nature Immunology · doi:10.1038/ni0603-503 · Cited by 240
Hypoxia-like tissue injury as a component of multiple sclerosis lesions
Lassmann, H. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00421-5 · Cited by 218
Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity
Giuliani, F., Goodyer, C. G., Antel, J. P., & Yong, V. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.368 · Cited by 215
Spinal cord axonal loss in multiple sclerosis: a post‐mortem study
Ganter, Prince, & Esiri (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00205.x · Cited by 202
Franklin, R. J. M., Gilson, J. M., & Blakemore, W. F. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971015)50:2<337::aid-jnr21>3.0.co;2-3 · Cited by 200
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
Geurts, J. J. G. (2003) · Brain · doi:10.1093/brain/awg179 · Cited by 194
Review: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
Bechtold, D. A., Kapoor, R., & Smith, K. J. (2004) · Annals of Neurology · doi:10.1002/ana.20045 · Cited by 192
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Papadopoulos, D., Dukes, S., Patel, R., Nicholas, R., Vora, A., & Reynolds, R. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00177.x · Cited by 192
Cortical motor reorganization after a single clinical attack of multiple sclerosis
Pantano, P. (2002) · Brain · doi:10.1093/brain/awf164 · Cited by 192
Remyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
Trapp, B. D., Ransohoff, R. M., Fisher, E., & Rudick, R. A. (1999) · The Neuroscientist · doi:10.1177/107385849900500107 · Cited by 190
Self-citationLo, A. C., Saab, C. Y., Black, J. A., & Waxman, S. G. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00434.2003 · Cited by 188
Kornek, B. (2001) · Brain · doi:10.1093/brain/124.6.1114 · Cited by 185
Fisher, E., Rudick, R. A., Cutter, G., Baier, M., Miller, D., Weinstock-Guttman, B., Mass, M. K., Dougherty, D. S., & Simonian, N. A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600602 · Cited by 185
Parpura, V., Scemes, E., & Spray, D. C. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.12.011 · Cited by 178
Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis
Narayana, P. A. (2005) · Journal of Neuroimaging · doi:10.1177/1051228405284200 · Cited by 177
Handbook of Multiple Sclerosis
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-583_3 · Cited by 167
Randomized multicenter trial of natalizumab in acute MS relapses: Clinical and MRI effects
O’Connor, P. W., Goodman, A., Willmer-Hulme, A. J., Libonati, M. A., Metz, L., Murray, R. S., Sheremata, W. A., Vollmer, T. L., Stone, L. A., & the Natalizumab Multiple Sclerosis Trial Group (2004) · Neurology · doi:10.1212/01.wnl.0000128136.79044.d6 · Cited by 167
Matthews, P. M., Pioro, E., Narayanan, S., Stefano, N. D., Fu, L., Francis, G., Antel, J., Wolfson, C., & Arnold, D. L. (1996) · Brain · doi:10.1093/brain/119.3.715 · Cited by 165
Evolution of a neuroprotective function of central nervous system myelin
Yin, X., Baek, R. C., Kirschner, D. A., Peterson, A. C., Fujii, Y., Nave, K., Macklin, W. B., & Trapp, B. D. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200509174 · Cited by 164
Self-citationBeatty, W. W., Paul, R. H., Wilbanks, S. L., Hames, K. A., Blanco, C. R., & Goodkin, D. E. (1995) · Neurology · doi:10.1212/wnl.45.4.718 · Cited by 161
Rocca, M. A., Mezzapesa, D. M., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., Comı, G., & Filippi, M. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00043-0 · Cited by 158
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis
Vogt, J., Paul, F., Aktas, O., Müller‐Wielsch, K., Dörr, J., Dörr, S., Bharathi, B. S., Glumm, R., Schmitz, C., Steinbusch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21719 · Cited by 157
Cortical pathology in multiple sclerosis
Stadelmann, C., Albert, M., Wegner, C., & Brück, W. (2008) · Current Opinion in Neurology · doi:10.1097/01.wco.0000318863.65635.9a · Cited by 147
Membranes, Myelin, and the Pathophysiology of Multiple Sclerosis
Waxman, S. G. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062505 · Cited by 143
Sodium Channels and Multiple Sclerosis: Roles in Symptom Production, Damage and Therapy
Smith, K. J. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00066.x · Cited by 139
Cortical lesions and brain atrophy in MS
Kutzelnigg, A., & Lassmann, H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.027 · Cited by 136
Imaging correlates of axonal swelling in chronic multiple sclerosis brains
Fisher, E., Chang, A., Fox, R. J., Tkach, J. A., Svarovsky, T., Nakamura, K., Rudick, R. A., & Trapp, B. D. (2007) · Annals of Neurology · doi:10.1002/ana.21113 · Cited by 136
Self-citationAxonal protection achieved in a model of multiple sclerosis using lamotrigine
Bechtold, D. A., Miller, S. J., Dawson, A. C., Sun, Y., Kapoor, R., Berry, D. J., & Smith, K. J. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0204-1 · Cited by 130
Gray matter pathology in (chronic) MS: Modern views on an early observation
Geurts, J. J. G., Stys, P. K., Minagar, A., Amor, S., & Zivadinov, R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.018 · Cited by 119
Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve
Waxman, S. G., Black, J. A., Stys, P. K., & Ransom, B. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)90806-k · Cited by 116
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
Black, J. A., Liu, S., Hains, B. C., Saab, C. Y., & Waxman, S. G. (2006) · Brain · doi:10.1093/brain/awl216 · Cited by 116
Ho, T. W., McKhann, G. M., & Griffin, J. W. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.187 · Cited by 116
Imaging correlates of decreased axonal Na + /K + ATPase in chronic multiple sclerosis lesions
Young, E. A., Fowler, C. D., Kidd, G. J., Chang, A., Rudick, R. A., Fisher, E., & Trapp, B. D. (2008) · Annals of Neurology · doi:10.1002/ana.21381 · Cited by 116
Self-citationGoodin, D., Cohen, B. A., O'Connor, P. W., Kappos, L., & Stevens, J. C. (2008) · Neurology · doi:10.1212/01.wnl.0000320512.21919.d2 · Cited by 115
Papadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Miller, R. H., & Mi, S. (2007) · Nature Neuroscience · doi:10.1038/nn1995 · Cited by 114
Multiple Sclerosis and Glutamate
Groom, A., Smith, T., & Turski, L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07533.x · Cited by 109
Black, J. A., Liu, S., Carrithers, M. D., Carrithers, L. M., & Waxman, S. G. (2007) · Annals of Neurology · doi:10.1002/ana.21172 · Cited by 108
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors
Ouardouz, M., Coderre, E., Basak, A., Chen, A. A., Zamponi, G. W., Hameed, S., Rehak, R., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21533 · Cited by 108
Self-citationChanges in Activated T Cells in the Blood Correlate With Disease Activity in Multiple Sclerosis
Khoury, S. J., Guttmann, C. R. G., Orav, E. J., Kikinis, R., Jolesz, F. A., & Weiner, H. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1183 · Cited by 108
Functional MRI in Multiple Sclerosis
Rocca, M. A., & Filippi, M. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00135.x · Cited by 107
Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
Ouardouz, M., Coderre, E., Zamponi, G. W., Hameed, S., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21539 · Cited by 107
Self-citationFunctional Brain Reorganization in Multiple Sclerosis: Evidence from fMRI Studies
Pantano, P., Mainero, C., & Caramia, F. (2006) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2006.00029.x · Cited by 105
Bennett, J. L., & Stüve, O. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181880359 · Cited by 104
MR Spectroscopy in Multiple Sclerosis
Stefano, N. D., & Filippi, M. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00134.x · Cited by 99
Association of a Null Mutation in the CNTF Gene With Early Onset of Multiple Sclerosis
Giess, R., Mäurer, M., Linker, R. A., Gold, R., Warmuth‐Metz, M., Toyka, K. V., Sendtner, M., & Rieckmann, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.407 · Cited by 99
Martino, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00771-9 · Cited by 94
Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons
Stys, P. K., & Jiang, Q. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00469-x · Cited by 93
Dutta, R., McDonough, J. A., Chang, A., Swamy, L., Siu, A., Kidd, G. J., Rudick, R. A., Mirnics, K., & Trapp, B. D. (2007) · Brain · doi:10.1093/brain/awm206 · Cited by 87
Self-citationNeurogenesis in the chronic lesions of multiple sclerosis
Chang, A., Smith, M. C., Yin, X., Fox, R. J., Staugaitis, S. M., & Trapp, B. D. (2008) · Brain · doi:10.1093/brain/awn157 · Cited by 85
Self-citationConventional MRI in Multiple Sclerosis
Filippi, M., & Rocca, M. A. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00129.x · Cited by 85
Sodium Channel Expression Within Chronic Multiple Sclerosis Plaques
Black, J. A., Newcombe, J., Trapp, B. D., & Waxman, S. G. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181462841 · Cited by 84
Self-citationNeuroprotection of axons with phenytoin in experimental allergic encephalomyelitis
Lo, A., Black, J. A., & Waxman, S. G. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00015 · Cited by 83
Sodium-mediated axonal degeneration in inflammatory demyelinating disease
Bechtold, D. A., & Smith, K. J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.003 · Cited by 80
Multiple Sclerosis as a Neuronal Disease
Waxman, S. G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.22 · Cited by 79
Dubois-Dalcq, M. E., Williams, A., Stadelmann, C., Stankoff, B., Zalc, B., & Lubetzki, C. (2008) · Brain · doi:10.1093/brain/awn076 · Cited by 79
Disease-Modifying Agents for Multiple Sclerosis: Recent Advances and Future Prospects
Menge, T., Weber, M. S., Hemmer, B., Kieseier, B. C., von Büdingen, H. ‐., Warnke, C., Zamvil, S. S., Boster, A. L., Khan, O., Hartung, H. P., et al. (2008) · Drugs · doi:10.2165/0003495-200868170-00004 · Cited by 72
Myelin repair strategies: a cellular view
Gallo, V., & Armstrong, R. C. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fd1875 · Cited by 65
Handbook of Multiple Sclerosis
Jellinger, K. A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00375.x · Cited by 63
Glial Cell Developmentbasic principles and clinical relevance
Jessen, K. R., & Richardson, W. D. (1997) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9781872748542.001.0001 · Cited by 62
Glial cell development. Basic principles and clinical relevance
Jensen, N. A. (1996) · FEBS Letters · doi:10.1016/0014-5793(97)81272-0 · Cited by 56
Substantial early, but nonprogressive neuronal loss in multiple sclerosis (ms) spinal cord
Schirmer, L., Albert, M., Buss, A., Schulz‐Schaeffer, W. J., Antel, J. P., Brück, W., & Stadelmann, C. (2009) · Annals of Neurology · doi:10.1002/ana.21799 · Cited by 56
Imaging neuronal and axonal degeneration in multiple sclerosis
de Stefano, N., Guidi, L., Stromillo, M., Bartolozzi, M. L., & Federico, A. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0175-2 · Cited by 50
Stys, P. K., Lehning, E. J., Saubermann, A. J., & LoPachin, R. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051920.x · Cited by 48
Multiple Sclerosis As A Neuronal Disease
(2005) · Elsevier eBooks · doi:10.1016/b978-0-12-738761-1.x5000-7 · Cited by 46
Treating multiple sclerosis with monoclonal antibodies: a 2010 update
Buttmann, M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.38 · Cited by 45
Functional Magnetic Resonance Imaging and Multiple Sclerosis: The Evidence for Neuronal Plasticity
Buckle, G. J. (2005) · Journal of Neuroimaging · doi:10.1177/1051228405284093 · Cited by 36
Pathology of Multiple Sclerosis
Prineas, J. W. (2001) · CRC Press eBooks · doi:10.1201/9780824741846-16 · Cited by 36
Sodium channel blockers and axonal protection in neuroinflammatory disease
Waxman, S. G. (2004) · Brain · doi:10.1093/brain/awh353 · Cited by 34
Regeneration of oligodendrocytes and myelin
Dubois-Dalcq, M. E. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)90084-5 · Cited by 30
Phenytoin protects central axons in experimental autoimmune encephalomyelitis
Black, J. A., & Waxman, S. G. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.001 · Cited by 28
Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis
Rieckmann, P., & Mäurer, M. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00022 · Cited by 26
Stefano, N. D., Narayanan, S., Matthews, P., Mortilla, M., Dotti, M. T., Federico, A., & Arnold, D. L. (2000) · PubMed · Cited by 25
Axonal Degeneration in Multiple Sclerosis: The Histopathological Evidence
Peterson, J. W., Kidd, G. J., & Trapp, B. D. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50013-4 · Cited by 24
Self-citationHoffmann, V., Pöhlau, D., Przuntek, H., Epplen, J. T., & Hardt, C. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363818 · Cited by 22
Evidencias en favor de una pérdida axonal primaria en la esclerosis múltiple
Anthony, D. C., Hughes, P., & Perry, V. H. (2000) · Revista de Neurología · doi:10.33588/rn.3012.99548 · Cited by 10
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.032 · Cited by 665
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Will the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Werneburg, S., Jung, J., Kunjamma, R. B., Ha, S.-K., Luciano, N. J., Willis, C. M., Gao, G., Biscola, N. P., Havton, L. A., Crocker, S. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.004 · Cited by 440
microRNA dysregulation in neurodegenerative diseases: A systematic review
Juźwik, C. A., S. Drake, S., Zhang, Y., Paradis-Isler, N., Sylvester, A., Amar-Zifkin, A., Douglas, C., Morquette, B., Moore, C. S., & Fournier, A. E. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101664 · Cited by 426
Metadata
- Authors
- Dutta, R., & Trapp, B. D.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 93
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2006178657
- Cited by
- 457
- References
- 174
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.